Abstract
A new series of bisindole based sulfonates (4a-t) have been synthesized and evaluated for their anticancer activity against various human cancer cell lines. Some of these compounds exhibited good inhibitory activity against most of the cell lines tested. Interestingly all the compounds from the bisindole sulfonate series exhibited selective inhibition against MCF-7 cell line. Further these compounds have also been tested for their inhibition of tubulin polymerization. The compounds 4a, 4l, 4n, 4r and 4t demonstrated a dose dependent tubulin inhibition with IC50 values of 2.3, 1.7, 8.1, 6.0 and 10 μM, respectively. Thus, results have demonstrated that antiproliferative activity of these compounds is related to their inhibition of tubulin polymerization.
Keywords: Anticancer activity, Indoles, Sulfonates, Tubulin polymerization, Bisindole Sulfonates, cyclin-dependent kinases (CDKs), antiangiogenic, heterocyclic ring system, indole, mitomycin, cytotoxicity, Micro mass, Column chromatography
Letters in Drug Design & Discovery
Title: Synthesis, Anticancer Activity and Inhibition of Tubulin Polymerization of Bisindole Sulfonates
Volume: 9 Issue: 3
Author(s): Ahmed Kamal, Y. V.V. Srikanth, M. Naseer Ahmed Khan, Md. Ashraf, Thokhir Basha Shaik and Shasi V. Kalivendi
Affiliation:
Keywords: Anticancer activity, Indoles, Sulfonates, Tubulin polymerization, Bisindole Sulfonates, cyclin-dependent kinases (CDKs), antiangiogenic, heterocyclic ring system, indole, mitomycin, cytotoxicity, Micro mass, Column chromatography
Abstract: A new series of bisindole based sulfonates (4a-t) have been synthesized and evaluated for their anticancer activity against various human cancer cell lines. Some of these compounds exhibited good inhibitory activity against most of the cell lines tested. Interestingly all the compounds from the bisindole sulfonate series exhibited selective inhibition against MCF-7 cell line. Further these compounds have also been tested for their inhibition of tubulin polymerization. The compounds 4a, 4l, 4n, 4r and 4t demonstrated a dose dependent tubulin inhibition with IC50 values of 2.3, 1.7, 8.1, 6.0 and 10 μM, respectively. Thus, results have demonstrated that antiproliferative activity of these compounds is related to their inhibition of tubulin polymerization.
Export Options
About this article
Cite this article as:
Kamal Ahmed, V.V. Srikanth Y., Naseer Ahmed Khan M., Ashraf Md., Basha Shaik Thokhir and V. Kalivendi Shasi, Synthesis, Anticancer Activity and Inhibition of Tubulin Polymerization of Bisindole Sulfonates, Letters in Drug Design & Discovery 2012; 9 (3) . https://dx.doi.org/10.2174/157018012799129774
DOI https://dx.doi.org/10.2174/157018012799129774 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Paramagnetic Contrast Agents for Molecular Imaging and Targeted Drug Delivery
Current Pharmaceutical Biotechnology Proteins in Microglial Activation - Inputs and Outputs by Subsets
Current Protein & Peptide Science Risk Stratification of Dyslipidemia: Insights from the Framingham Study
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Stem Cells in Cardiovascular Regeneration: From Preservation of Endogenous Repair to Future Cardiovascular Therapies
Current Pharmaceutical Design Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes
Current Drug Targets Substrates, Inhibitors and Activators of P-glycoprotein: Candidates for Radiolabeling and Imaging Perspectives
Current Topics in Medicinal Chemistry Hormetic Potential of Sulforaphane (SFN) in Switching Cells’ Fate Towards Survival or Death
Mini-Reviews in Medicinal Chemistry Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Strategies for Salt Reduction in Foods
Recent Patents on Food, Nutrition & Agriculture Redox mechanisms in pathological angiogenesis in the retina: roles for NADPH oxidase
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Medicinal Chemistry Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence
Current Pharmaceutical Design Genome-wide Analysis of Myelodysplastic Syndromes
Current Pharmaceutical Design Potentials of Hydrogels in Cancer Therapy
Current Cancer Therapy Reviews Relevance of Protein Isoforms in Proteomic Studies
Current Proteomics Disulfiram, and Disulfiram Derivatives as Novel Potential Anticancer Drugs Targeting the Ubiquitin Proteasome System in Both Preclinical and Clinical Studies
Current Cancer Drug Targets Disorders of Protein Biogenesis and Stability
Protein & Peptide Letters Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells
Current Cancer Drug Targets Recent Advances in Hematopoietic Stem Cell-Mediated Regeneration
Recent Patents on Regenerative Medicine Soy Isoflavones and Exercise: Possible Benefits for Postmenopausal Womens Cardiovascular Health
Current Women`s Health Reviews